1. Home
  2. TRVI vs KRNT Comparison

TRVI vs KRNT Comparison

Compare TRVI & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • KRNT
  • Stock Information
  • Founded
  • TRVI 2011
  • KRNT 2002
  • Country
  • TRVI United States
  • KRNT Israel
  • Employees
  • TRVI N/A
  • KRNT N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • KRNT Industrial Machinery/Components
  • Sector
  • TRVI Health Care
  • KRNT Industrials
  • Exchange
  • TRVI Nasdaq
  • KRNT Nasdaq
  • Market Cap
  • TRVI 725.7M
  • KRNT 845.4M
  • IPO Year
  • TRVI 2019
  • KRNT 2015
  • Fundamental
  • Price
  • TRVI $7.42
  • KRNT $15.09
  • Analyst Decision
  • TRVI Strong Buy
  • KRNT Strong Buy
  • Analyst Count
  • TRVI 9
  • KRNT 5
  • Target Price
  • TRVI $19.50
  • KRNT $31.40
  • AVG Volume (30 Days)
  • TRVI 1.8M
  • KRNT 358.2K
  • Earning Date
  • TRVI 08-07-2025
  • KRNT 08-06-2025
  • Dividend Yield
  • TRVI N/A
  • KRNT N/A
  • EPS Growth
  • TRVI N/A
  • KRNT N/A
  • EPS
  • TRVI N/A
  • KRNT N/A
  • Revenue
  • TRVI N/A
  • KRNT $207,639,000.00
  • Revenue This Year
  • TRVI N/A
  • KRNT $10.86
  • Revenue Next Year
  • TRVI N/A
  • KRNT $12.68
  • P/E Ratio
  • TRVI N/A
  • KRNT N/A
  • Revenue Growth
  • TRVI N/A
  • KRNT N/A
  • 52 Week Low
  • TRVI $2.36
  • KRNT $12.78
  • 52 Week High
  • TRVI $8.11
  • KRNT $34.29
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 59.47
  • KRNT 25.00
  • Support Level
  • TRVI $7.08
  • KRNT $12.78
  • Resistance Level
  • TRVI $7.74
  • KRNT $19.26
  • Average True Range (ATR)
  • TRVI 0.42
  • KRNT 1.01
  • MACD
  • TRVI -0.05
  • KRNT -0.70
  • Stochastic Oscillator
  • TRVI 55.77
  • KRNT 24.89

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

Share on Social Networks: